ALB and hepatocellular carcinoma: Additionally, we developed an HCC mouse model by genetically engineering hepatocyte-specific PKM2 knockout Alb-CreERT2; PKM2loxp/loxp; Rosa26RFP mice and Alb-CreERT2; Rosa26RFP mice to investigate the impact of PKM2 depletion in vivo.